Oral News and Research

RSS

Gut microbiota can help predict occurrence of colorectal cancer

Gut microbiota - the population of microbes that live in our intestine - can be used to predict the occurrence of colorectal cancer, the second most common type of cancer in women and the third in men.

1 Apr 2019

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.

29 Mar 2019

FDA approves new oral treatment for men with certain forms of hypogonadism

The U.S. Food and Drug Administration today approved Jatenzo (testosterone undecanoate), an oral testosterone capsule to treat men with certain forms of hypogonadism.

27 Mar 2019

Male contraceptive pill crosses the human clinical trial hurdle

Birth control pills have been around for the past six decades but have been for use of women only. A team of researchers this week have announced the success of the first male birth control pill that could safely prevent pregnancy.

27 Mar 2019

Impact of legalizing cannabis on the opioid crisis

Legislators believe that the passage of cannabis access laws will play a significant role in addressing the ongoing opioid crisis.

26 Mar 2019

A1c blood test found to be unreliable in diabetes diagnoses

Research has found that many cases of diabetes are missed when the hemoglobin A1c blood test is used solely to diagnose the disease.

26 Mar 2019

Research shows financial and quality-of-life toll of intravenous therapy on parents, caregivers

When treating patients, doctors sometimes overlook how their decisions impact a world they never see: a patient's home life. In the case of some serious infections in children, oral antimicrobial drugs are just as good at treating these ailments at home as the standard, intravenous medications.

26 Mar 2019

Study evaluates prescribing of preventive drugs at the end of life in older adults with cancer

A new study reveals that preventive medications--such as those to lower blood pressure or cholesterol, or to protect bone health, among others--are commonly prescribed during the last year of life of older adults with cancer, even though they are unlikely to provide meaningful benefits.

25 Mar 2019

Bisphosphonates to treat osteoporosis appears to be beneficial for all women

In recent years, women who start taking bisphosphonates to treat osteoporosis and prevent fracture have trended from younger to older and from having osteopenia to having osteoporosis, researchers report.

25 Mar 2019

Inherited form of rickets improves more with new injectable medicine than conventional therapy

Burosumab, a new injectable medicine to treat X-linked hypophosphatemia (XLH), an inherited form of rickets, demonstrates superior improvements in rickets and other outcomes compared with conventional therapy in an international, phase 3 clinical trial in children.

25 Mar 2019

Hemoglobin A1c blood test may underestimate prevalence of diabetes

Using the hemoglobin A1c blood test to diagnose diabetes tends to underestimate the prevalence of the disease, according to a new study to be presented Saturday, March 23 at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

25 Mar 2019

Hemoglobin A1c blood test does not detect diabetes in most patients, shows study

The hemoglobin A1c blood test is widely used to diagnose type 1 and type 2 diabetes, but it is actually unable to detect the disease in most patients, according to a new study presented Saturday, March 23, at a news conference at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

25 Mar 2019

New survey indicates need of attention to neglected tropical diseases

Although neglected diseases account for 11% of the global disease burden, they are targeted by only a small proportion of the new drugs developed every year.

22 Mar 2019

Repurposing drugs to outsmart cancers

In an article published today by SAGE Publishing, investigators from The Nagourney Cancer Institute and The Albert Einstein Israelite Hospital in São Paulo, Brazil, announced a new approach to identifying effective treatments for patients with advanced metastatic cancers. A drug commonly used to treat kidney and liver cancer was discovered effective for breast cancer, which may open new drug therapies to patients regardless of tumor type.

22 Mar 2019

Naltrexone implant more effective in reducing relapses in HIV patients with opioid addiction

When patients with HIV who are also battling opioid dependence go without addiction treatment, they are more likely to stop taking their HIV medications than drug-free patients.

22 Mar 2019

Brain area that only processes spoken, not written words identified

Patients in a new Northwestern Medicine study were able to comprehend words that were written but not said aloud. They could write the names of things they saw but not verbalize them.

22 Mar 2019

Most pills contain common allergens, warn experts

Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study.

20 Mar 2019

FDA warns marketer of unapproved products claiming to treat addiction, chronic pain

The U.S. Food and Drug Administration today posted a warning letter to Nutra Pharma Corp. for illegally marketing unapproved products labeled as homeopathic with claims about their ability to treat addiction and chronic pain, including pain associated with cancer, diabetes, shingles, fibromyalgia and other serious conditions.

19 Mar 2019

Adolescent daily users more likely to obtain electronic cigarettes from commercial sources

University of Cincinnati research on adolescent use of electronic cigarettes was featured prominently at the American Academy of Health Behavior 2019 Annual Scientific Meeting on Monday, March 11, in Greenville, South Carolina.

19 Mar 2019

Partial oral antibiotic therapy shows efficacy and safety in patients with infectious endocarditis

Patients with an infection of the inner lining on the left side of the heart (endocarditis) who were switched from intravenous to oral antibiotic therapy had better long-term survival and fewer complications than similar patients who remained on conventional intravenous antibiotic therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

18 Mar 2019

Oral News and Research

Gut microbiota can help predict occurrence of colorectal cancer

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

FDA approves new oral treatment for men with certain forms of hypogonadism

Male contraceptive pill crosses the human clinical trial hurdle

Impact of legalizing cannabis on the opioid crisis

A1c blood test found to be unreliable in diabetes diagnoses

Research shows financial and quality-of-life toll of intravenous therapy on parents, caregivers

Study evaluates prescribing of preventive drugs at the end of life in older adults with cancer

Bisphosphonates to treat osteoporosis appears to be beneficial for all women

Inherited form of rickets improves more with new injectable medicine than conventional therapy

Hemoglobin A1c blood test may underestimate prevalence of diabetes

Hemoglobin A1c blood test does not detect diabetes in most patients, shows study

New survey indicates need of attention to neglected tropical diseases

Repurposing drugs to outsmart cancers

Naltrexone implant more effective in reducing relapses in HIV patients with opioid addiction

Brain area that only processes spoken, not written words identified

Most pills contain common allergens, warn experts

FDA warns marketer of unapproved products claiming to treat addiction, chronic pain

Adolescent daily users more likely to obtain electronic cigarettes from commercial sources

Partial oral antibiotic therapy shows efficacy and safety in patients with infectious endocarditis

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News